BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37171333)

  • 21. Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
    Liang JF; Chen YT; Fuh JL; Li SY; Chen TJ; Tang CH; Wang SJ
    Cephalalgia; 2015 Mar; 35(3):203-10. PubMed ID: 24853165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.
    Chen CH; Lin CL; Kao CH
    Osteoporos Int; 2016 Jun; 27(6):2117-26. PubMed ID: 26860609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
    Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
    J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glaucoma correlates with increased risk of Parkinson's disease in the elderly: a national-based cohort study in Taiwan.
    Lai SW; Lin CL; Liao KF
    Curr Med Res Opin; 2017 Aug; 33(8):1511-1516. PubMed ID: 28436278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Tuberculosis and Parkinson Disease: A Nationwide, Population-Based Cohort Study.
    Shen CH; Chou CH; Liu FC; Lin TY; Huang WY; Wang YC; Kao CH
    Medicine (Baltimore); 2016 Feb; 95(8):e2883. PubMed ID: 26937925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between proton pump inhibitors use and risk of asthma in Korea: A prevalent new-user cohort study.
    Lim HJ; Oh IS; Noh Y; Yon DK; Shin JY
    Medicine (Baltimore); 2024 Jan; 103(1):e36772. PubMed ID: 38181266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study.
    Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ
    Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital-based case-control study and a population-based cohort study.
    Yee J; Han HW; Gwak HS
    Br J Clin Pharmacol; 2022 Jun; 88(6):2738-2746. PubMed ID: 34970788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Parkinson's disease following severe constipation: a nationwide population-based cohort study.
    Lin CH; Lin JW; Liu YC; Chang CH; Wu RM
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1371-5. PubMed ID: 25293395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton pump inhibitor use and risk of hip fracture in patients with type 2 diabetes.
    Chou YS; Jiang HJ; Chen CH; Ho PS; Lee TC
    Sci Rep; 2020 Aug; 10(1):14081. PubMed ID: 32826941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
    Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
    Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive association of Parkinson's disease with ankylosing spondylitis: a nationwide population-based study.
    Yeh FC; Chen HC; Chou YC; Lin CL; Kao CH; Lo HY; Liu FC; Yang TY
    J Transl Med; 2020 Nov; 18(1):455. PubMed ID: 33256841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased risk of overactive bladder in patients with idiopathic Parkinson's disease: Insight from a nationwide population-based cohort study.
    Lin FY; Yang YC; Lin CL; Lee LJ
    PLoS One; 2018; 13(3):e0193783. PubMed ID: 29499067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
    Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
    Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children.
    Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
    JAMA Pediatr; 2021 Apr; 175(4):394-403. PubMed ID: 33555324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between chronic obstructive pulmonary disease and Parkinson's disease: a nationwide population-based retrospective cohort study.
    Li CH; Chen WC; Liao WC; Tu CY; Lin CL; Sung FC; Chen CH; Hsu WH
    QJM; 2015 Jan; 108(1):39-45. PubMed ID: 25024356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of Parkinson's disease in patients with hypothyroidism: A nationwide population-based cohort study.
    Chen SF; Yang YC; Hsu CY; Shen YC
    Parkinsonism Relat Disord; 2020 May; 74():28-32. PubMed ID: 32294589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonarteritic anterior ischemic optic neuropathy and incidence of Parkinson's disease based on a nationwide population based study.
    Ahn JH; Kang MC; Youn J; Park KA; Han KD; Jung JH
    Sci Rep; 2024 Feb; 14(1):2930. PubMed ID: 38316950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased risk of Parkinson's disease among patients with age-related macular degeneration.
    Chen PJ; Wan L; Lai JN; Chen CS; Chen JJ; Yen WM; Chiu LT; Hu KC; Tien PT; Lin HJ
    BMC Ophthalmol; 2021 Dec; 21(1):426. PubMed ID: 34886822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.